Phosphoramidate alkylator prodrugs for the treatment of cancer
US8552048B2 · kind B2 · utility
1Cited by
32References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2007 |
| Grant date | Oct 8, 2013 |
| Priority date | — |
| Expiry date | Feb 3, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions containing, and, methods administering, TH302, are useful in treatment of cancer and other hyper-proliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.